Swedencare AB (publ)

OM:SECARE Stock Report

Market Cap: SEK 4.1b

Swedencare Valuation

Is SECARE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of SECARE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: SECARE (SEK25.95) is trading below our estimate of future cash flow value (SEK101.81)

Significantly Below Future Cash Flow Value: SECARE is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SECARE?

Key metric: As SECARE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SECARE. This is calculated by dividing SECARE's market cap by their current earnings.
What is SECARE's PE Ratio?
PE Ratio84.1x
EarningsSEK 49.30m
Market CapSEK 4.15b

Price to Earnings Ratio vs Peers

How does SECARE's PE Ratio compare to its peers?

The above table shows the PE ratio for SECARE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average54.4x
CAMX Camurus
51x34.45%SEK 34.8b
MCAP MedCap
36.4x14.86%SEK 8.2b
BIOG B BioGaia
37.2x18.17%SEK 12.3b
DVYSR Devyser Diagnostics
92.8x60.31%SEK 1.4b
SECARE Swedencare
84.1x50.20%SEK 4.1b

Price-To-Earnings vs Peers: SECARE is expensive based on its Price-To-Earnings Ratio (84.1x) compared to the peer average (54.4x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does SECARE's PE Ratio compare vs other companies in the European Pharmaceuticals Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
SECARE 84.1xIndustry Avg. 21.5xNo. of Companies10PE020406080100+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SECARE is expensive based on its Price-To-Earnings Ratio (84.1x) compared to the European Pharmaceuticals industry average (21.5x).

Price to Earnings Ratio vs Fair Ratio

What is SECARE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SECARE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio84.1x
Fair PE Ratio66.4x

Price-To-Earnings vs Fair Ratio: SECARE is expensive based on its Price-To-Earnings Ratio (84.1x) compared to the estimated Fair Price-To-Earnings Ratio (66.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SECARE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 25.95
SEK 42.00
+61.85%
7.14%SEK 45.00SEK 39.00n/a2
Jun ’27SEK 26.15
SEK 42.00
+60.61%
7.14%SEK 45.00SEK 39.00n/a2
May ’27SEK 26.90
SEK 47.00
+74.72%
17.02%SEK 55.00SEK 39.00n/a2
Apr ’27SEK 25.35
SEK 47.00
+85.40%
17.02%SEK 55.00SEK 39.00n/a2
Mar ’27SEK 25.10
SEK 47.00
+87.25%
17.02%SEK 55.00SEK 39.00n/a2
Feb ’27SEK 24.25
SEK 48.00
+97.94%
12.84%SEK 55.00SEK 40.00n/a3
Jan ’27SEK 38.40
SEK 51.67
+34.55%
4.56%SEK 55.00SEK 50.00n/a3
Dec ’26SEK 36.95
SEK 51.67
+39.83%
4.56%SEK 55.00SEK 50.00n/a3
Nov ’26SEK 38.40
SEK 51.67
+34.55%
4.56%SEK 55.00SEK 50.00n/a3
Oct ’26SEK 34.05
SEK 47.67
+39.99%
12.86%SEK 55.00SEK 40.00n/a3
Sep ’26SEK 39.55
SEK 49.67
+25.58%
10.04%SEK 55.00SEK 43.00n/a3
Aug ’26SEK 37.60
SEK 49.67
+32.09%
10.04%SEK 55.00SEK 43.00n/a3
Jul ’26SEK 44.15
SEK 53.67
+21.56%
9.17%SEK 60.00SEK 48.00SEK 25.303
Jun ’26SEK 40.00
SEK 54.33
+35.83%
7.71%SEK 60.00SEK 50.00SEK 26.153
May ’26SEK 38.60
SEK 54.33
+40.76%
7.71%SEK 60.00SEK 50.00SEK 26.903
Apr ’26SEK 39.30
SEK 56.33
+43.34%
5.09%SEK 60.00SEK 53.00SEK 25.353
Mar ’26SEK 42.50
SEK 57.00
+34.12%
3.79%SEK 60.00SEK 55.00SEK 25.103
Feb ’26SEK 50.20
SEK 58.67
+16.87%
6.58%SEK 64.00SEK 55.00SEK 24.253
Jan ’26SEK 48.24
SEK 58.67
+21.61%
6.58%SEK 64.00SEK 55.00SEK 38.403
Dec ’25SEK 49.60
SEK 58.67
+18.28%
6.58%SEK 64.00SEK 55.00SEK 36.953
Nov ’25SEK 45.78
SEK 58.67
+28.15%
6.58%SEK 64.00SEK 55.00SEK 38.403
Oct ’25SEK 43.64
SEK 63.00
+44.36%
1.59%SEK 64.00SEK 62.00SEK 34.052
Sep ’25SEK 40.74
SEK 63.00
+54.64%
1.59%SEK 64.00SEK 62.00SEK 39.552
Aug ’25SEK 44.98
SEK 63.00
+40.06%
1.59%SEK 64.00SEK 62.00SEK 37.602
Jul ’25SEK 59.00
SEK 67.00
+13.56%
4.48%SEK 70.00SEK 64.00SEK 44.152
SEK 42
Fair Value
38.2% undervalued intrinsic discount
2
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/02 00:16
End of Day Share Price 2026/07/02 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Swedencare AB (publ) is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Johan BrownABG Sundal Collier Sponsored
Adela DashianJefferies LLC
Adrian ElmlundNordea Markets